Insulet (PODD)
(Delayed Data from NSDQ)
$171.40 USD
+2.22 (1.31%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $171.41 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Average Brokerage Rating
Current ABR | 1.39 |
ABR (Last week) | 1.39 |
# of Recs in ABR | 18 |
Average Target Price | $234.94 |
LT Growth Rate | 18.10% |
Industry | Medical - Products |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | 0.39 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 14 | 14 | 14 | 14 | 14 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/23/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
12/21/2023 | Robert W. Baird & Co. | Jeffrey D Johnson | Hold | Strong Buy |
11/3/2023 | Canaccord Genuity | William J Plovanic | Not Available | Strong Buy |
10/16/2023 | SVB Securities | Michael Kratky | Not Available | Strong Buy |
10/4/2023 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
9/15/2023 | Raymond James | Jayson T Bedford | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.